Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CAMBREX CORPORATION

(CBM)
SummaryNewsCompany 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Cambrex Completes Major Expansion of Solid Form Screening Facility in Edinburgh

10/12/2020 | 04:00am EDT

Cambrex, announced the completion of an expansion of its solid form screening and crystallization process development facility in Edinburgh, Scotland. This major expansion project has seen the facility's total footprint doubled to 15,000 square feet, with existing laboratory space having been refurbished, and an additional 3,500 square feet of laboratory space added. Cambrex's Edinburgh site is a world-class facility, providing solid form development services for drug substance and drug product. These include solid state investigations such as salt, co-crystal, and polymorph screening, in addition to crystallization process development and GMP analytical services. The expert scientists at the site work on projects both as a standalone service to a range of pharmaceutical innovators, as well as liaising with other Cambrex sites to offer an integrated process development service. The expansion has added an additional 13 fume cupboards to the laboratory, including three that are "walk-in", which will allow the Edinburgh team to increase capacity and provide its clients with larger process crystallization development, up to 20-liter scale. The site currently has 50 employees, and the expansion will add additional laboratory space to enable the recruitment of up to 40 more scientists, with the potential for further growth in the future.


© S&P Capital IQ 2020
All news about CAMBREX CORPORATION
10/07Cambrex to Invest $30 Million to Expand Manufacturing Center of Excellence At High Poin..
CI
06/23Omega Therapeutics Expands Board of Directors with Appointment of Luke Beshar
CI
05/26Cambrex Introduces New Kilogram-Scale Gmp Manufacturing Capabilities At Tallinn, Estoni..
CI
05/05Cambrex Expands Analytical Services Capabilities at Longmont, Colorado, Facility
CI
2020Cambrex to Invest $50 Million to Expand Multipurpose Large-Scale Manufacturing Capabili..
CI
2020Cambrex Completes Major Expansion of Solid Form Screening Facility in Edinburgh
CI
2020Cambrex Increases Flexible Manufacturing Capacity at Karlskoga, Sweden Facility
CI
2020Cambrex Appoints Thomas Loewald as Member of the Board of Directors Effective September..
CI
2020Cambrex Appoints Thomas Loewald as Chief Executive Officer Effective September 7, 2020
CI
2020Cambrex Announces Board Changes
CI
More news
Managers and Directors
Thomas W. Loewald Chief Executive Officer & Director
Wayne M. Hewett Chairman
Claes Johan Robert Glassell Director
Henry Minello Director
Laura O'Donnell Director
Sector and Competitors
1st jan.Capi. (M$)
CAMBREX CORPORATION0.00%2 023
JOHNSON & JOHNSON2.49%424 619
ROCHE HOLDING AG16.59%339 442
NOVO NORDISK A/S54.22%234 792
PFIZER, INC.12.71%232 621
ELI LILLY AND COMPANY40.89%215 657